Dendritic cells: tools and targets for antitumor vaccination (Q36284556)

13 August 2017

1 reference

title

Dendritic cells: tools and targets for antitumor vaccination (English)

1 reference

13 August 2017

1 reference

Stefan Nierkens

2

0 references

Carl Figdor

object named as

Carl G Figdor

3

0 references

Gosse J Adema

5

object named as

Gosse J Adema

1 reference

13 August 2017

Martijn H M G M den Brok

1

1 reference

PubMed ID

16221071

13 August 2017

Theo J M Ruers

4

1 reference

PubMed ID

16221071

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

Expert Review of Vaccines

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

5

1 reference

13 August 2017

699-710

1 reference

Recent advances in dendritic cell biology

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Dendritic cells as therapeutic vaccines against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Plasmacytoid dendritic cells: linking innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Immunotherapy of cancer with dendritic-cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Cancer immunotherapy with mRNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Antigen bias in T cell cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Danger signals: a time and space continuum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

TLR11 activation of dendritic cells by a protozoan profilin-like protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Migration of dendritic cell based cancer vaccines: in vivo veritas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

CpG oligodeoxynucleotide enhances tumor response to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

The induction of tolerance by dendritic cells that have captured apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Successful combination of local CpG-ODN and radiotherapy in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

CTLA-4: new insights into its biological function and use in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

Immunosuppressive effects of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.699

21 January 2018

Identifiers

DOI

10.1586/14760584.4.5.699

1 reference

13 August 2017

1 reference

PubMed ID

16221071